Search results for " END"

showing 10 items of 4885 documents

Leisure-time physical activity and intra-abdominal fat in young adulthood: A monozygotic co-twin control study

2016

Objective To investigate differences in abdominal fat compartments between young adult monozygotic twin pairs discordant for leisure-time physical activity. Methods Ten young adult male monozygotic twin pairs (age range 32-36 years) discordant for leisure-time physical activity during the past 3 years were systematically selected from a population-based Finnish twin cohort. Magnetic resonance image at the level of the L2-L3 intervertebral disc was used to predict intra-abdominal and subcutaneous abdominal fat masses. Dietary intake was assessed with a 4-day food diary. Results Inactive twins had 31% more intra-abdominal fat than their active co-twins (mean difference 0.52 kg, 95% CI 0.12 to…

medicine.medical_specialtyIntra-Abdominal FatEndocrinology Diabetes and MetabolismPopulationMedicine (miscellaneous)Monozygotic twin030209 endocrinology & metabolismDiet Records03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineMedicineYoung adulteducation2. Zero hungereducation.field_of_studyNutrition and Dieteticsbusiness.industry030229 sport sciencesmedicine.diseaseObesityEndocrinologyCohortbusinessBody mass indexObesity
researchProduct

Robotic Hysterectomy in Severely Obese Patients With Endometrial Cancer: A Multicenter Study

2015

Abstract Study Objective The aim of this study was to evaluate the surgical and oncologic outcomes of robotic hysterectomy with or without or less pelvic and aortic lymphadenectomy in severely obese patients (body mass index [BMI] ≥ 40 kg/m 2 ) with endometrial cancer. Material and Methods Between August 2010 and November 2014, patients with histologically confirmed endometrial cancer and BMI ≥40 kg/m 2 were deemed eligible for the study and underwent RH with or without pelvic and aortic lymphadenectomy. Results Seventy patients were divided into 3 groups according to their BMI: group A, BMI between 40 and 45 kg/m 2 (50 patients); group B, BMI between 45 and 50 kg/m 2 (10 patients); and gro…

medicine.medical_specialtyIntraoperative Complicationmedicine.medical_treatmentHysterectomyBody Mass Index03 medical and health sciencesPostoperative Complications0302 clinical medicineRobotic Surgical ProceduresEndometrial cancerLaparotomymedicineHumansObesityRobotic hysterectomyMorbidIntraoperative ComplicationsLaparoscopyAged030219 obstetrics & reproductive medicineHysterectomymedicine.diagnostic_testbusiness.industryMedicine (all)Endometrial cancerObstetrics and GynecologyPostoperative complicationLength of StayMiddle Agedmedicine.diseaseEndometrial NeoplasmsObesity MorbidSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIA030220 oncology & carcinogenesisLymph Node ExcisionFemaleLaparoscopyLymphadenectomyEndometrial cancer; Morbidity obese; Robotic hysterectomy; Aged; Body Mass Index; Endometrial Neoplasms; Female; Humans; Intraoperative Complications; Length of Stay; Lymph Node Excision; Middle Aged; Obesity Morbid; Postoperative Complications; Hysterectomy; Laparoscopy; Robotic Surgical Procedures; Obstetrics and Gynecology; Medicine (all)businessBody mass indexMorbidity obeseJournal of Minimally Invasive Gynecology
researchProduct

Intravenöse Eisensubstitution bei chronischer Erkrankung – bei wem, wann und wie?

2019

ZusammenfassungIn den letzten Jahren konnten wesentliche Fortschritte in der Erkennung und Behandlung des Eisenmangels erzielt werden, deren Ergebnisse auch für viele Fachgebiete und insbesondere mit Patienten mit chronisch-entzündlichen Erkrankungen relevant sind. Allerdings wird in der täglichen Praxis ein Eisenmangel vielfach nicht identifiziert und konsequent therapiert.Ein Eisenmangel kann – auch bevor eine Anämie auftritt – die Lebensqualität einschränken und den Verlauf der Grunderkrankung beeinflussen. Bei Patienten mit chronischen Erkrankungen sollte der Eisenstatus regelmäßig erfasst werden. Gerade bei Patienten mit chronisch-entzündlichen Erkrankungen sind die derzeit verfügbaren…

medicine.medical_specialtyIron uptakebusiness.industryAnemiaIRON PREPARATIONS030232 urology & nephrology10265 Clinic for Endocrinology and Diabetology610 Medicine & healthGeneral MedicineIron deficiency2700 General Medicine030204 cardiovascular system & hematologymedicine.diseaseEnteral administrationGastroenterology03 medical and health sciences0302 clinical medicineTolerabilityQuality of lifeInternal medicinemedicineIn patientbusiness
researchProduct

AMP-activated protein kinase (AMPK) signaling pathway: A potential mechanism involved in PAFIYAMA syndrome?

2016

medicine.medical_specialtyLeft atriumAMP-Activated Protein KinasesProtein Serine-Threonine Kinases030204 cardiovascular system & hematologyleft atrium03 medical and health sciences0302 clinical medicineAMP-activated protein kinaseFibrosisInternal medicinemedicineHumansAmpk signalingPhosphorylationPotential mechanismremodelingendurancebiologyexercisebusiness.industryfibrosismedicine.diseaseCell biologyEnzyme Activationmedicine.anatomical_structureEndocrinologybiology.proteinexercise; endurance; arrhythmias; fibrosis; remodeling; left atriumCardiology and Cardiovascular Medicinebusinessarrhythmias030217 neurology & neurosurgerySignal Transduction
researchProduct

Reply to Letter to the Editor “Polypharmacy in elderly people with diabetes admitted to hospital”

2015

medicine.medical_specialtyLetter to the editorEndocrinology Diabetes and MetabolismEndocrinology; Internal Medicine; Endocrinology Diabetes and Metabolism030209 endocrinology & metabolism030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusDiabetes MellitusInternal MedicinemedicineHumansMetabolic studyElderly peopleMetabolic diseaseCognitive impairmentAgedPolypharmacybusiness.industryPublic healthGeneral Medicinemedicine.diseaseHospitalizationDiabetes and MetabolismEmergency medicinePolypharmacybusinessActa Diabetologica
researchProduct

Reply to Drs. Kiaei and Molinaro Regarding the Publication “Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody D…

2020

Dear Editor,Drs. Kiaei and Molinaro 1 put forth two criticisms of the manuscript published by us 2. They state that the experimental design of this study is flawed and that the authors falsely claim that negative Thyretain™ TSI Reporter BioAssay results for two Graves’ diseases patients undergoing drug treatments means the absence of stimulating antibodies. To substantiate this claim Drs. Kiaei and Molinaro point out that the manufacturer of the Thyretain TSI Reporter BioAssay clearly states in the package insert that “[t]he effects of various drug therapies on the performance of this Kit have not been established” 1. Second, the package insert explicitly states that “[a] negative result do…

medicine.medical_specialtyLetter to the editorPackage insertEndocrinology Diabetes and MetabolismClinical BiochemistryThyrotropin receptor Antibody030209 endocrinology & metabolismBiochemistryAntibodies03 medical and health sciences0302 clinical medicineEndocrinologyClinical historyInternal medicineClinical informationHumansMedicineBioassayLetter to the EditorImmunoassaymedicine.diagnostic_testbusiness.industryBiochemistry (medical)Receptors ThyrotropinGeneral MedicineGraves DiseasePatient population030220 oncology & carcinogenesisImmunoassaybusinessImmunoglobulins Thyroid-StimulatingHormone and Metabolic Research
researchProduct

Response, Letter to the Editor: Author Response to Mustafa Sahin.

2016

medicine.medical_specialtyLetter to the editorbusiness.industryEndocrinology Diabetes and MetabolismBiochemistry (medical)Clinical BiochemistryMEDLINELibrary science030209 endocrinology & metabolismBiochemistry03 medical and health sciences0302 clinical medicineEndocrinologyEndocrinologyInternal medicinemedicine030212 general & internal medicinebusinessThe Journal of clinical endocrinology and metabolism
researchProduct

Comparison of anesthetic efficacy of 4% articaine with 1:100,000 epinephrine and 2% lidocaine with 1:80,000 epinephrine for inferior alveolar nerve b…

2014

Objectives: This study was done to compare the anesthetic efficacy of 4% articaine with 1:100,000 epinephrine with that of 2% lidocaine with 1:80,000 epinephrine during pulpectomy in patients with irreversible pulpitis for inferior alveolar nerve block in mandibular posterior teeth. Material and Methods: Patients with irreversible pulpitis referred to the Department of Conservative Dentistry and Endodontics, K.D. Dental College, randomly received a conventional inferior alveolar nerve block containing 1.8 mL of either 4% articaine with 1:100,000 epinephrine or 2% lidocaine with 1:80,000 epinephrine. After the patient's subjective assessment of lip anesthesia, the absence/presence of pulpal …

medicine.medical_specialtyLidocainebusiness.industryLocal anestheticmedicine.drug_classResearchDentistryOdontologíaInferior alveolar nervemedicine.diseaseEndodonticsArticaine:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludOperative Dentistry and EndodonticsEpinephrinestomatognathic systemAnesthesiaAnestheticUNESCO::CIENCIAS MÉDICASmedicinePulpitisbusinessGeneral Dentistrymedicine.drug
researchProduct

Pulmonary hypertension and right ventricular dysfunction in heart failure: prognosis and 15‐year prospective longitudinal trajectories in survivors

2020

Aims Systolic pulmonary artery pressure (SPAP), tricuspid annular plane systolic excursion (TAPSE), and TAPSE/SPAP ratio trajectories are not fully characterized in chronic heart failure (HF). We assessed very long-term longitudinal SPAP, TAPSE and TAPSE/SPAP trajectories in HF patients, and their dynamic changes in outcomes. Methods and results Prospective, consecutive, observational registry of real-life HF patients, performing echocardiography studies at baseline and according to a prospectively structured schedule after 1 year, and then every 2 years, up to 15 years. Pulmonary hypertension (PH) was defined as SPAP ≥40 mmHg; right ventricular dysfunction (RVD) was defined at TAPSE ≤16 mm…

medicine.medical_specialtyLong term follow upHypertension PulmonaryVentricular Dysfunction Right030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinemedicine.arteryInternal medicinemedicineClinical endpointHumansIn patientProspective StudiesSurvivorsHeart Failurebusiness.industryPrognosismedicine.diseasePulmonary hypertensionRight ventricular dysfunctionstomatognathic diseasesHeart failurePulmonary arteryCohortVentricular Function RightCardiologyCardiology and Cardiovascular MedicinebusinessEuropean Journal of Heart Failure
researchProduct

Does Systemic Low-Grade Inflammation Associate With Fat Accumulation and Distribution? A 7-Year Follow-Up Study With Peripubertal Girls

2014

Knowledge about the interrelationship between adiposity and systemic low-grade inflammation during pubertal growth is important in detecting early signs of obesity-related metabolic disorders.The objective of the study was to evaluate the developmental trajectories of fat mass (FM) and high sensitive C-reactive protein (hsCRP) levels and factors that could explain the relationship between FM and hsCRP in girls from prepuberty to early adulthood.This was a 7.5-year longitudinal study.The study was conducted at the University of Jyväskylä Sports and Health Science laboratory.Three hundred ninety-six healthy Finnish girls aged 11.2 ± 0.8 years participated in the study.Body composition was ass…

medicine.medical_specialtyLongitudinal studyAdolescentEndocrinology Diabetes and MetabolismClinical BiochemistryAdipokine030209 endocrinology & metabolismContext (language use)Biochemistry03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinePrepubertymedicineBody Fat DistributionHumansObesity030212 general & internal medicineChildFinlandInflammationAdiponectinbusiness.industryLeptinPubertyBiochemistry (medical)Lipid Metabolismmedicine.diseaseObesityC-Reactive ProteinEndocrinologyAdipose TissueMenarcheFemalebusinessFollow-Up StudiesThe Journal of Clinical Endocrinology & Metabolism
researchProduct